223 related articles for article (PubMed ID: 36057262)
1. Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma.
Xu C; Li Y; Su W; Wang Z; Ma Z; Zhou L; Zhou Y; Chen J; Jiang M; Liu M
Aging (Albany NY); 2022 Sep; 14(17):6917-6935. PubMed ID: 36057262
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma.
Hua S; Xie Z; Zhang Y; Wu L; Shi F; Wang X; Xia S; Dong S; Jiang J
Front Immunol; 2022; 13():869297. PubMed ID: 35936012
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
4. Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy.
Ma J; Kang Z; Yang G; Wang X; Si M; Wang Y; Li G; Bai S; Zeng F; Li M; Wang Z; Wang L; Xu W
Front Biosci (Landmark Ed); 2023 Dec; 28(12):334. PubMed ID: 38179741
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
Front Immunol; 2022; 13():861328. PubMed ID: 35479084
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
Front Immunol; 2022; 13():934243. PubMed ID: 36189255
[TBL] [Abstract][Full Text] [Related]
7. SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma.
Jiang A; Liu Y; Zhu B; Fang Y; Qu L; Yang Q; Luo P; Cai C; Wang L
Clin Genitourin Cancer; 2024 Apr; 22(2):497-513. PubMed ID: 38245436
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
[TBL] [Abstract][Full Text] [Related]
9. A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy.
Wang Y; Liu J; Zhang L; Li Y
Dis Markers; 2022; 2022():6402599. PubMed ID: 35845137
[TBL] [Abstract][Full Text] [Related]
10. Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing.
Weng KQ; Liu JY; Li H; She LL; Qiu JL; Qi H; Qi HY; Li YS; Dai YB
Int Immunopharmacol; 2024 Mar; 130():111746. PubMed ID: 38442575
[TBL] [Abstract][Full Text] [Related]
11. Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy.
Liu J; Xu J; Zhang T; Xu K; Bao P; Zhang Z; Xue K; He R; Ma L; Wang Y
Front Immunol; 2022; 13():791158. PubMed ID: 35812372
[TBL] [Abstract][Full Text] [Related]
12. Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy.
Bai D; Feng H; Yang J; Yin A; Qian A; Sugiyama H
Cancer Sci; 2021 Jun; 112(6):2126-2139. PubMed ID: 33735492
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma.
Yao Q; Zhang X; Wang Y; Wang C; Wei C; Chen J; Chen D
Eur J Med Res; 2024 Jan; 29(1):22. PubMed ID: 38183155
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Evaluation of the m
Yu M; Liu X; Xu H; Shen S; Wang F; Chen D; Li G; Wang Z; Zuo Z; Zhao A
Front Immunol; 2022; 13():818120. PubMed ID: 35784363
[TBL] [Abstract][Full Text] [Related]
17. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
Wei K; Zhang X; Yang D
PeerJ; 2023; 11():e16643. PubMed ID: 38130918
[TBL] [Abstract][Full Text] [Related]
19. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.
Liu Y; Qi L; Ye B; Wang A; Lu J; Qu L; Luo P; Wang L; Jiang A
Cancer Biol Ther; 2024 Dec; 25(1):2345977. PubMed ID: 38659199
[TBL] [Abstract][Full Text] [Related]
20. Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy.
Lin E; Zhu P; Ye C; Huang M; Liu X; Tian K; Tang Y; Zeng J; Cheng S; Liu J; Liu Y; Yu Y
Front Immunol; 2022; 13():830220. PubMed ID: 35677048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]